Background The growing use of imaging procedures in the United States has raised concerns
about exposure to low-dose ionizing radiation in the general population. Methods We …

OBJECTIVE: To design a functional, patient-centered model of patient complexity with
practical applicability to analytic design and clinical practice. Existing literature on patient …

Objectives : The purpose of this study was to determine the lifetime burden and risk factors
for hospitalization after heart failure (HF) diagnosis in the community. Background : …

OBJECTIVE Hypoglycemia is a cause of significant morbidity among patients with diabetes
and may be associated with greater risk of death. We conducted a retrospective study to …

Background : Dose reduction of non–vitamin K antagonist oral anticoagulants (NOACs) is
indicated in patients with atrial fibrillation (AF) with renal impairment. Failure to reduce the …

We have conducted a pragmatic clinical trial aimed to assess whether an electrocardiogram
(ECG)-based, artificial intelligence (AI)-powered clinical decision support tool enables early …

Background The introduction of non–vitamin K antagonist oral anticoagulants has been a
major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in …

Background: Patients with end-stage kidney disease (ESKD) on dialysis were excluded from
clinical trials of direct oral anticoagulants for atrial fibrillation (AF). Recent data have raised …

Background. The value of rapid, panel-based molecular diagnostics for positive blood culture
bottles (BCBs) has not been rigorously assessed. We performed a prospective randomized …

Background In comparison to warfarin, non–vitamin K antagonist oral anticoagulants ( NOAC
s) have the advantages of ease of dosing, fewer drug interactions, and lack of need for …